Status:
COMPLETED
Using PET-CT to Target and Validate Low-frequency TMS as Treatment for Tinnitus
Lead Sponsor:
University of Arkansas
Collaborating Sponsors:
Tinnitus Research Consortium
Conditions:
Tinnitus
Eligibility:
All Genders
19-65 years
Phase:
NA
Brief Summary
One out of every five people experience tinnitus (a buzzing, ringing, or roaring sound in the ear) ranging from mild to severe impairment. To date there is no effective therapy that seems to help the ...
Detailed Description
Subjects will be up to 20 right-handed patients (men and women), 19-65 years of age, with debilitating unilateral or bilateral tinnitus. All subjects must report experiencing the presence of their pha...
Eligibility Criteria
Inclusion
- right-handed subjects
- 19-65 years of age
- debilitating unilaterial or bilateral tinnitus
- Experiencing the presence of phantom auditory preception for \>6 months
- Tinnitus Handicap Questionnaire score of \>30
Exclusion
- significant neurological disease
- acoustic neuromas or glomus tumors
- active Meniere's disease
- profound hearing loss
- non English speaking
- personal or family history of epilepsy
- personal history of head injury, aneurysm, stroke, previous cranial neurosurgery, neurological or psychiatric disorders, metal implants in the head or neck, a pacemaker, pregnancy, migraines,
- medications that lower seizure threshold and are contraindicated
- individuals who have been taking certain medications
- claustrophobia
- patients who do not exhibit significant cortical asymmetries on PET
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2008
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT00329524
Start Date
June 1 2006
End Date
August 1 2008
Last Update
May 4 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States, 72205